TABITHA GARRISON: Open Payments
NPI 1205990983 · BROADWAY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 70 payments from 14 companies in 2025. Trend: 2023 $889 · 2024 $807 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $254 |
| Boston Scientific Corporation | 5 | $229 |
| Collegium Pharmaceutical, Inc. | 13 | $227 |
| PFIZER INC. | 15 | $204 |
| Tonix Medicines, Inc. | 3 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $85 |
| Novo Nordisk Inc | 2 | $47 |
| Lundbeck LLC | 2 | $47 |
| Lilly USA, LLC | 3 | $46 |
Products named: NURTEC ODT, Intracept, Belbuca, UBRELVY, JOURNAVX, QULIPTA, XTAMPZA, RELISTOR.
Industry payments across VA — which companies pay providers there.
